GlassScriptPhysician profile
Joseph Mishkin
NPI 1376692640
$23,038.53
in general payments reported to CMS, 2019-2025
7 companies · $20K in 2025
The $20K reported for 2025 was more than what 84% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2021: $140 · 2022: $475 · 2023: $555 · 2024: $1,519 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $4,375 · Travel and Lodging: $2,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,075.00 |
| Food and Beverage | $4,374.61 |
| Travel and Lodging | $2,351.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,319.33 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, 2nd Gen Centrimag Primary Console |
| Abiomed | $2,122.68 | 2019-2025 | Impella |
| Cvrx, INC. | $483.87 | 2024-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.74 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $24.09 | 2023 | |
| Biotronik INC. | $23.20 | 2025 | |
| Pfizer INC. | $22.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mishkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.